105 related articles for article (PubMed ID: 23149155)
1. Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?
Dumortier J; Guillaud O; Gagnieu MC; Janbon B; Juillard L; Morelon E; Leroy V
J Clin Virol; 2013 Feb; 56(2):146-9. PubMed ID: 23149155
[TBL] [Abstract][Full Text] [Related]
2. Future perspectives: towards interferon-free regimens for HCV.
Gane E
Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
Liu CH; Kao JH
J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.
Werner CR; Franz C; Egetemeyr DP; Janke-Maier P; Malek NP; Lauer UM; Berg CP
J Viral Hepat; 2014 May; 21(5):333-40. PubMed ID: 24716636
[TBL] [Abstract][Full Text] [Related]
6. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
[TBL] [Abstract][Full Text] [Related]
7. Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection.
Picchio G; De Meyer S; Dierynck I; Ghys A; Gritz L; Kieffer TL; Bartels DJ; Witek J; Bengtsson L; Luo D; Kauffman RS; Adda N; Sarrazin C
J Clin Virol; 2014 Mar; 59(3):148-55. PubMed ID: 24462470
[TBL] [Abstract][Full Text] [Related]
8. A case report: antiviral triple therapy with telaprevir in a haemodialysed HCV patient in Turkey.
Akhan S; Sayan M; Sargin Altunok E; Aynioglu A
Acta Clin Belg; 2015 Dec; 70(6):440-1. PubMed ID: 26790555
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of telaprevir-containing triple therapy in the treatment of chronic hepatitis C in hemodialysed patients.
Kaya S; Aksoz S; Baysal B; Ay N; Danis R
Infect Dis (Lond); 2015 Sep; 47(9):658-61. PubMed ID: 25936530
[TBL] [Abstract][Full Text] [Related]
10. Telaprevir: a hepatitis C NS3/4A protease inhibitor.
Matthews SJ; Lancaster JW
Clin Ther; 2012 Sep; 34(9):1857-82. PubMed ID: 22951253
[TBL] [Abstract][Full Text] [Related]
11. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
12. Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner.
De Nicolò A; Boglione L; Ciancio A; Cusato J; Strona S; Cardellino CS; Abdi AM; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G; D'Avolio A
Antiviral Res; 2014 Sep; 109():7-14. PubMed ID: 24956496
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis C virus infection after liver transplantation.
Agarwal K; Barnabas A
Dig Liver Dis; 2013 Sep; 45 Suppl 5():S349-54. PubMed ID: 24091115
[TBL] [Abstract][Full Text] [Related]
14. Preemptive antiviral treatment for hepatitis C virus after living donor liver transplantation.
Sugawara Y; Tamura S; Yamashiki N; Kaneko J; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N
Transplant Proc; 2012 Apr; 44(3):791-3. PubMed ID: 22483497
[TBL] [Abstract][Full Text] [Related]
15. Futility rules for telaprevir combination treatment for patients with hepatitis C virus infection.
Adda N; Bartels DJ; Gritz L; Kieffer TL; Tomaka F; Bengtsson L; Luo D; Jacobson IM; Kauffman RS; Picchio G
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):193-5. PubMed ID: 23159528
[TBL] [Abstract][Full Text] [Related]
16. Triple therapy in chronic hepatitis C: initial series in a public health program in the South of Brazil.
Almeida PR; Fonseca CB; Koch VW; Souza AM; Feltrin AA; Tovo CV
Arq Gastroenterol; 2015; 52(1):14-7. PubMed ID: 26017076
[TBL] [Abstract][Full Text] [Related]
17. Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis.
De Nicola S; Aghemo A; Campise MR; D'Ambrosio R; Rumi MG; Messa P; Colombo M
Antivir Ther; 2014; 19(5):527-31. PubMed ID: 24009104
[TBL] [Abstract][Full Text] [Related]
18. Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C.
Karino T; Ozeki I; Hige S; Kimura M; Arakawa T; Nakajima T; Kuwata Y; Sato T; Ohmura T; Toyota J
J Viral Hepat; 2014 May; 21(5):341-7. PubMed ID: 24001168
[TBL] [Abstract][Full Text] [Related]
19. Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?
Matsui K; Kamijo-Ikemori A; Sugaya T; Ikeda H; Okuse C; Shibagaki Y; Yasuda T; Kimura K
Nephrology (Carlton); 2015 Nov; 20(11):843-8. PubMed ID: 25998031
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
